Johnson & Johnson says testing of coronavirus vaccine to begin by September

(Reuters) - Johnson & Johnson (JNJ.N) said on Monday human testing of its experimental vaccine for the coronavirus would begin by September and that it could be available for emergency use authorization in early 2021.

J&J also said it had committed more than $1 billion of investment along with U.S. agency Biomedical Advanced Research and Development Authority to co-fund vaccine research.

Reporting by Manas Mishra in Bengaluru; Editing by Bernard Orr

Our Standards:The Thomson Reuters Trust Principles.
Reuters, 30 Mar, 2020

More Business & Finance News

Buffett-backed BYD to supply EV batteries to Ford

View detail

Worst may be over for euro zone factories, recovery to be slow: PMI

View detail

Stocks scale 3-month peak, dollar sags on reopening joy

View detail

Emirates president says could take four years to rebuild network from virus hit

View detail

Disclaimer: All information on this page are taken from third party reliable sources of relevant industry channels, with simple aim just for general information for our users. Hamariweb never endorse or recommend for any trading advice as well as accuracy of data provided here.